T h e re is considerable concern about increasing rates of dru g -related mortality in the UK. Evidence has suggested that recently released offenders are at a high risk of dying from dru grelated causes. This study provides estimates of the rates of mortality amongst re c e n t l y released prisoners in England and Wales and provides some evidence of the risk factors associated with this group. The sampling exercise was undertaken prior to the implementation of the revised prison service drug strategy which brought in a considerable expansion in the provision of treatment and support for drug misusers.
• T h e re was a high rate of death from all causes in the immediate post-release period:
• 13 deaths in the first week after release (55 deaths per thousand per annum)
• 6 in the second week (25 deaths per thousand per annum)
• 3 -4 per week in the third and fourth weeks (15 deaths per thousand per annum).
After this, the rate of death declined to a steady rate of about two deaths per week (between 5 and 10 deaths per thousand per annum).
• In the week following release, prisoners in the sample were about 40 times more likely to die than the general population. In this period, immediately post-release, most of these deaths (over 90%) were associated with dru g -related causes.
• The age of the prisoner at the time of release was associated with the risk of death from both d ru g -related and other causes. Prisoners aged 25 to 39 at the time of release were most at risk.
• Of the 79 dru g -related deaths, just over half (53%) were re c o rded as involving only one dru g .
A single drug with alcohol was re c o rded in 13% of cases, mixed drugs without alcohol in 19% and mixed drugs with alcohol in 14% of cases. In 71% of all cases, hero i n / m o r p h i n e w e re specifically mentioned either by the coroner or in the toxicology re p o rt .
• In a small group of prisoners interviewed while in prison as part of a survey of the mental health of prisoners carried out in 1997, risk factors for dru g -related death included:
• living off crime before coming to prison
• having a small primary support group (3 people or fewer)
• being in prison for a sex offence (main off e n c e )
• a history of illicit use of tranquillisers 
Mortality rates
From a sample of 12,438 prisoners discharged in England and Wales during either June or December 1999, 137 deaths were re c o rded in the study period up to 31 January 2001. Of these, 79 were dru g -related and 58 were fro m other causes. The mortality rates for the year after re l e a s e f rom prison were 5.2 per thousand per annum for m o rtality from dru g -related causes and 3.8 per thousand for other causes.
The mortality rate from all causes declined rapidly as length of time after discharge increased, from 55 deaths per thousand per annum during the first week after discharge to approximately half this figure (25 per thousand per annum) during the second week after discharge. It then halved again to approximately 15 per thousand during the third and fourth weeks after discharge. Thereafter the rate varies between five and ten per thousand for the remainder of the first year after discharge. The decline in the mortality rate for all causes after release was largely due to a decline in the dru g -related mortality rate. The dru g -re l a t e d mortality rate decreased from 50 per thousand per annum in the first week after release to 17 per thousand per annum in the second week and then to about four or five per thousand per annum thereafter.
It was also possible to compare these mortality rates with the general population (excess mortality ratio), matched for gender, age and observation period, based on deaths in England and Wales in 1999. Over the study period as a whole, 23 deaths in the general population would be expected compared to the total of 137 observed deaths. In the week immediately following release, prisoners in the sample were about 40 times more likely to die than a member of the general population. In this period immediately post-release, over 90% of the deaths among Findings 187 2 released prisoners were associated with dru g -re l a t e d causes. A measure of the extent of excess mortality specifically associated with the immediate post-release period can be obtained. The excess mortality ratio for the first week post-release is compared with that for the period three months or more after release, when mortality rates remained constant. The excess mortality ratio due to drugrelated causes for the first week post-release was 12.5 times greater than that for the period three months to one year post-release (see Figure 1) .
The age of the prisoner at the time of release was significantly associated with the risk of death from both drug-related and other causes. There was a higher than expected number of deaths in all age groups compared to the general population but the difference was greatest for prisoners aged 25 to 39 at the time of release. In this age group, there were more than ten times as many deaths as expected and about two-thirds of this excess mortality was due to drug-related causes.
Causes and circumstances of deaths
It has been estimated that use of multiple drugs (poly-dru g use) doubles the risk of mortality for every additional dru g used (Gossop et al., 2002) . Of the re c o rded 79 dru g -re l a t e d deaths, just over half (53%) involved only a single drug, with a single drug mixed with alcohol in 13% of cases. Use of multiple drugs without alcohol was re c o rded in 19% of cases and poly-drug use with alcohol occurred in 14% of re c o rd e d cases. There f o re, alcohol is implicated significantly in o v e rdose deaths.
Opiates (for example, heroin) were the most frequently recorded type of drug involved in drug-related deaths in toxicology reports. Heroin/morphine was mentioned in It was also possible to deduce whether death was accidental or deliberate suicide based on coroners' verdicts -only one of the drug-related deaths was considered to be suicide. In addition, information about where death occurred was available for just under half the drug-related death cases. A large proportion of deaths occurred in residential settings, suggesting that it is possible that family members or friends may have observed the deterioration. If this is the case, further education for family members in the recognition and management of overdose may help prevent some deaths.
There were a number of deaths where the underlying cause of death was specifically alcohol-related and others where alcohol was mentioned as a contributory factor. In total amongst all deaths, 11 deaths were classified as alcoholrelated and alcohol was found to be a contributory factor or found present in the body in a further 23 cases (21 of these were drug-related deaths).
Risk factors for drug-related mortality
Information on deaths occurring among a separate, smaller sample of prisoners was also collected. They were interviewed for a survey of the mental health of prisoners carried out by the Office of National Statistics in 1997. Among the sample of 2,545 prisoners who had been released by the time of this study, there had been 25 drugFindings 187 3 related deaths and 21 deaths from other causes. As the following findings from this survey were based on very small numbers they should be interpreted with caution. Logistic re g ression analysis was used to examine factors associated with dru g -related mortality in this group of prisoners. This indicated that risk of dru g -related death after release was higher among those who were :
• living off crime before their prison sentence • separated, divorced or widowed
• had not been taken into local authority care
• had a small primary support gro u p
• had committed a sex offence as their main off e n c e
• had used illicit tranquillisers
• had used drugs in the month before entry into prison
• had not used drugs in prison.
Recommendations
Overall the determining factor in dru g -related deaths soon after release would appear to be altered tolerance to opioid type d rugs. Approaches to the reduction in dru g -related deaths in the early release period need to include an incre a s e d a w a reness of the risk of overdose. This is particularly import a n t when the offender relapses into drug use during the first weeks after release from prison.
• All prisoners as part of their release preparation should be made aware of the risk of drug-related death in the immediate post-release period as a result of the consumption of drugs.
• Individuals at higher risk of drug-related death should be identified and linked into ongoing after-care with community-based services immediately on release from prison. This should be part of a comprehensive and integrated approach to treatment in prison and the community. The CARAT scheme (Counselling, Assessment, Referral, Advice and Thro u g h -c a re ) should have a role in any such programme.
• C onsideration should be given to the establishment of a pilot study to investigate the feasibility of p roviding a methadone maintenance pro g r a m m e within prisons for individuals with long-standing opioid dependence.
• Naltrexone is an opioid receptor blocking agent -it has been suggested that it could be used as a medication to prevent relapse to heroin use. The return to previous patterns of heroin use after a period of abstinence in prison appears to be an important factor in the high drug-related mortality rates among n e w l y -released prisoners re p o rted here. This is probably due to an altered tolerance to heroin.
T h e re f o re, consideration should be given as to whether it would be appropriate to develop a pilot project to investigate the use of naltrexone. This Tricyclic anti-depre s s a n t s 6 5
Other named dru g 4 3 Unspecified dru g s 10 8
Note: * in many cases more than one type of drug was m e n t i o n e d
should include an evaluation of the likely impact on overdose risk and mortality.
• It appears from the death notifications reviewed in this study, that other people may have been present when a number of the drug-related deaths occurred. It is possible that the use of naloxone (similar to naltrexone) could have prevented deaths in some cases. Strang (1999) has proposed that the provision of naloxone could be a significant tool in reducing o p i o i d -related mort a l i t y. The potential for pilot programmes aimed at making naloxone more widely available in the community should also be considered and if successful might be extended to cover newlyreleased prisoners.
• The rates obtained in this study should be used as the basis for target-setting for the reduction in postrelease drug-related mortality. Further research on this topic should be conducted to extend the findings of this study.
